Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-03-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare dose levels of petrelintide versus placebo with regards to effect on body weight, safety, and tolerability.